SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon - Quaterly Results

21 Oct 2021 Evaluate
The sales slipped to Rs. 3648.00 millions, down -34.86% for the September 2021 quarter as against Rs. 5600.00 millions during the year-ago period.The Net Loss for the quarter ended September 2021 is Rs. -66.00 millions as compared to Net Profit of Rs. 950.00 millions of corresponding quarter ended September 2020The company reported a degrowth in operating Profit to 173.00 millions from 1263.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 3648.00 5600.00 -34.86 7475.00 10807.00 -30.83 20284.00 19884.00 2.01
Other Income 405.00 384.00 5.47 897.00 744.00 20.56 1502.00 2017.00 -25.53
PBIDT 173.00 1263.00 -86.30 900.00 2790.00 -67.74 4627.00 4877.00 -5.13
Interest 1.00 1.00 0.00 3.00 2.00 50.00 4.00 12.00 -66.67
PBDT 172.00 1262.00 -86.37 897.00 2788.00 -67.83 4623.00 6462.00 -28.46
Depreciation 265.00 264.00 0.38 525.00 521.00 0.77 1035.00 980.00 5.61
PBT -93.00 998.00 -109.32 372.00 2267.00 -83.59 3588.00 5482.00 -34.55
TAX -27.00 48.00 -156.25 147.00 469.00 -68.66 783.00 1119.00 -30.03
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -66.00 950.00 -106.95 225.00 1798.00 -87.49 2805.00 4363.00 -35.71
Equity 6003.00 6000.00 0.05 6003.00 6000.00 0.05 6000.00 6000.00 0.00
PBIDTM(%) 4.74 22.55 -78.97 12.04 25.82 -53.36 22.81 24.53 -7.00

Biocon Share Price

380.55 -2.05 (-0.54%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×